Postirradiation changes in the pelvis: assessment with MR imaging

Area of Science:

• Radiology
• Oncology
• Medical Imaging

Background:

• Pelvic radiation therapy can cause significant tissue toxicity.
• Assessing radiation-induced changes and differentiating them from recurrent tumors is clinically important.

Purpose of the Study:

• To evaluate magnetic resonance (MR) imaging features of pelvic radiation changes.
• To correlate MR findings with radiation dose, time post-treatment, and clinical symptoms.
• To assess the accuracy of MR imaging in distinguishing radiation damage from residual/recurrent tumors.

Main Methods:

• Retrospective analysis of MR imaging in 51 patients treated with pelvic radiation.
• Correlation of MR imaging findings with radiation dose (e.g., >4,500 cGy) and clinical data.
• Grading of MR imaging tissue changes and comparison with clinical toxicity.

Main Results:

• Radiation tissue toxicity increased significantly above 4,500 cGy, with marked bladder and rectal changes rising substantially.
• Dose-related MR imaging changes were observed in various pelvic organs.
• MR imaging accurately reflected clinical toxicity, with moderate/severe changes seen in patients with grade 2/3 symptoms.
• Minimal MR changes were noted in asymptomatic patients.
• Diagnostic accuracy for differentiating radiation damage from recurrent tumor varied by primary tumor site (excellent for cervical cancer, less so for rectal carcinoma).

Conclusions:

• MR imaging is valuable for assessing pelvic radiation changes and correlates well with radiation dose and clinical toxicity.
• MR imaging can help differentiate radiation damage from recurrent tumors, though accuracy varies by tumor site.